Norway Country Drug Report 2019

Drug-related research

In Norway, drug-related research covers drugs, alcohol, tobacco and, to a certain extent, gambling and performance-enhancing drugs. The drugs and alcohol field is a priority of the government’s investment in research and falls within the objectives of improving quality and developing skills in the alcohol and drugs field. The National Action Plan for the Alcohol and Drugs Field 2016-20 defines a strategy for developing drug-related research and sets a concrete budget to implement it. In general, the government assesses the need to increase knowledge about the effectiveness of the interventions and treatment that are offered to people with drug dependencies. In addition, the government has launched different Research Council programmes to increase research on substance use and related problems.

Recent studies include population-based and clinical epidemiology research, and basic biological, neurobiological, behavioural, social scientific and drug policy research. The main sources of funding for these research activities are government departments, partly through the Research Council of Norway and partly through the Directorate of Health. Studies are mainly conducted by the Norwegian Centre for Addiction Research and the Norwegian Institute of Public Health, as well as university departments and privately funded research institutes. Research findings are disseminated on websites and through scientific and non-scientific (national and international) journals.

Norway main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.